SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001193125-17-015519
Filing Date
2017-01-24
Accepted
2017-01-23 18:33:37
Documents
17
Period of Report
2017-01-23

Document Format Files

Seq Description Document Type Size
1 PREM14A d307733dprem14a.htm PREM14A 3407851
2 GRAPHIC g307733g06g54.jpg GRAPHIC 65198
3 GRAPHIC g307733g06m54.jpg GRAPHIC 78701
4 GRAPHIC g307733g11y77.jpg GRAPHIC 26592
5 GRAPHIC g307733g21j11.jpg GRAPHIC 24658
6 GRAPHIC g307733g56z83.jpg GRAPHIC 16586
7 GRAPHIC g307733g57f70.jpg GRAPHIC 22487
8 GRAPHIC g307733g62k76.jpg GRAPHIC 20634
9 GRAPHIC g307733g63k37.jpg GRAPHIC 101118
10 GRAPHIC g307733g72x19.jpg GRAPHIC 53706
11 GRAPHIC g307733g73d40.jpg GRAPHIC 114562
12 GRAPHIC g307733g79g77.jpg GRAPHIC 64504
13 GRAPHIC g307733g82b92.jpg GRAPHIC 60156
14 GRAPHIC g307733g82x90.jpg GRAPHIC 39938
15 GRAPHIC g307733g83z52.jpg GRAPHIC 33022
16 GRAPHIC g307733g88j14.jpg GRAPHIC 73207
17 GRAPHIC g307733g95x17.jpg GRAPHIC 72976
  Complete submission text file 0001193125-17-015519.txt   4605761
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-36620 | Film No.: 17542211
SIC: 2834 Pharmaceutical Preparations